| Name
|
Mycobacterium Tuberculosis Protein ag85a
|
| Other Name
|
Mycobacterium tuberculosis Protein Ag85A
|
| Sequence (Single letter abbreviations)
|
LTSELPGWLQANRHVKPTGS
|
| Sequence（Three letter abbreviations）
|
{Leu}{Thr}{Ser}{Glu}{Leu}{Pro}{Gly}{Trp}{Leu}{Gln}{Ala}{Asn}{Arg}{His}{Val}{Lys}{Pro}{Thr}{Gly}{Ser}
|
| Basic description
|
This is a T cell immunodominant CD8 peptide of the Ag85A mycobacterium tuberculosis protein, MHC class I H-2Ld-restricted epitope. Parenterally administered Mycobacterium bovis BCG vaccine confers only limited immune protection from pulmonary tuberculosis, and intranasal administration of vector-expressing AdAg85A represents an effective means of boosting immune protection by parenteral BCG vaccination.
|
| The molecular weight
|
2191.500
|
| Chemical formula
|
C97H155N29O29
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Santosuosso, M. et al. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun. Aug 2006 ;74(8):4634-43.
|
Mycobacterium Tuberculosis Protein ag85a
